Connecticut Clinical Research Foundation

Bristol, Connecticut 06010

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Eosinophilic Esophagitis (EoE) Clinical Trial
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission
Status: Enrolling, Phase IV
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Crohn Disease Clinical Trial
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Endocrinology, Gastroenterology Clinical Trial
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut Clinical Research Foundation
mi
from
Bristol, CT
Click here to add this to my saved trials